While FLT3-ITD has certainly been demonstrated as a transforming lesion in multiple cell models and clearly contributes strongly to leukemogenesis, it is not sufficient to fully transform primary hematopoietic cells or generate leukemia in mouse models. The gene discussed is FLT3; the disease is leukemia.